Given the growing number of survivors––22.1 million survivors of cancer by 2030 according to American Cancer Society estimates––specific services will be needed to deal with long-term side effects and tools to help them maintain their quality of life.
In October 2020, the Mayo Clinic and Google Health announced a joint initiative that focuses on applying Artificial Intelligence (AI) to radiation therapy planning and medical imaging. Experts from the Mayo Clinic and Google Health will apply AI to medical imaging.
It’s been said that cancer impacts us all, either directly or indirectly through someone we know. Until earlier this year, I mainly knew of cancer indirectly. My uncle was diagnosed with Stage 4 lung cancer just as the pandemic hit.
Sam Mazin is the founder and CTO of RefleXion Medical. Mazin joined SROA Soundboard--a podcast for SROA to discuss biology guided radiotherapy (BgRT) technology for radiation oncology. Catch up on the key highlights from Mazin's podcast.
November is Pancreatic Cancer Awareness Month. In 2020, more than 57,000 Americans will be diagnosed with pancreatic cancer. Although this is considered a rare cancer, it is the third leading cause of cancer-related deaths.
On Friday, October 30, Mark Coticchia, vice president for Innovation at Baptist Health South Florida, presented on driving a culture of innovation. He described innovation as the intentional process of developing a new product or service to address a need held by many. It’s a structured form of problem solving that is need-based and multidisciplinary.
On Wednesday, October 28, Dr. Kim Clarke, program manager, Extramural Discovery Sciences with the American Cancer Society (ACS), presented on cancer research insights from the last decade. Her presentation covered precision medicine, immunotherapy, cancer metabolism, metastasis and palliative care.
Alex Wirth joins SROA Soundboard, SROA's podcast for radiation oncology administrators to discuss cybersecurity risks that exist with the increased use of telehealth during the pandemic.
SROA recently hosted a COVID-19 Q&A webinar session with four Board members. The members discussed what their facilities are doing to manage the CDC guidelines and the changing dynamic of the COVID-19 pandemic. All questions asked during the webinar were from SROA members.
Susan Vannoni, founder and CEO of Radiation Oncology Consulting LLC (ROC), provides some helpful answers in this Q&A to common questions about treatment delivery and management of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). All codes listed in this Q&A are from the AMA CPT.